Who asks about TB-500 and the questions they bring
Searches start with a soft-tissue injury. The honest answer starts with what the human evidence does and does not show.
TL;DR
- TB-500 searches typically follow a tendon or ligament injury, or a podcast mention of recovery peptides.
- The repeating question is whether animal repair data translates to humans — the answer is incomplete.
- TB-500 is not legally available from 503A compounding pharmacies in the United States as of 2026.
What it is
TB-500 is a synthetic peptide that copies a 17-amino-acid section of thymosin beta-4 (in plain English: a small repair protein the body makes naturally). Researchers use the fragment because it appears to carry the active region of the larger protein (Goldstein et al., Annals of the New York Academy of Sciences, 2012).
How it works
Think of the body's repair process as a road crew responding to a pothole. TB-500 has been linked, in animal research, to two pieces of that work: helping form new small blood vessels and helping repair cells move toward an injury site. The mechanism comes from rats, mice, and cell studies. Human trial data is limited.
Who asks about it
Three groups usually arrive at this search. First, athletes and active adults dealing with a stubborn tendon or ligament. Second, post-surgery patients who want to know about recovery options. Third, people reading about longevity peptides who want to understand where TB-500 fits. The question is almost always practical: does it work in people, and can I legally get it?
What the research says
Published reviews describe effects on tendon repair, wound healing, and cardiac tissue models in animals (Goldstein et al., 2012). Human evidence is much thinner. Anyone considering TB-500 should know that line — it shapes every honest conversation a clinician would have about it.
What to know before considering it
The regulatory reality matters most right now. TB-500 sits on the FDA's Category 2 list. State-licensed 503A compounding pharmacies cannot prepare it for patients today. That is the door to talk through before any side-effect or dosing question.
The Halftime POV
We will not pretend the animal story is a human story. The animal data is consistent. The human data is mostly still ahead. And the U.S. access door is closed for now. We would rather say that clearly than dress up rodent results as a sure thing.
Related reading:
- TB-500 (thymosin beta-4): what this repair peptide is
- How TB-500 promotes angiogenesis and tissue healing
- Category 1 vs Category 2 peptides: the access framework
FAQ
Q: Who searches for TB-500? A: Mostly people nursing a soft-tissue injury — a tendon, a ligament, a stubborn shoulder — and people who heard about it on a recovery or longevity podcast. The shared question is whether the animal data carries over to humans.
Q: Is TB-500 the same as thymosin beta-4? A: TB-500 is a synthetic 17-amino-acid fragment of thymosin beta-4 (in plain English: the active piece of a larger repair protein the body makes). The fragment carries the part used in published research.
Q: Is TB-500 FDA-approved? A: No. TB-500 is not FDA-approved. As of 2026 it sits on the FDA's Category 2 list and is not currently available from 503A compounding pharmacies.
Disclaimer
As of May 2026, TB-500 is classified by the FDA as Category 2, which means it is not currently available from 503A compounding pharmacies. A February 2026 HHS announcement proposed returning these peptides to Category 1 pending formal FDA Federal Register notice. This article is educational and is not medical advice. Halftime Health only prescribes through licensed clinicians in states where our partner physicians are credentialed.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin beta4: a multi-functional regenerative peptide. Annals of the New York Academy of Sciences, 2012.
- FDA Category 1 and Category 2 Bulk Drug Substances 503A list.
This article discusses compounds that are currently under FDA Category 2 review (see our FDA categorization explainer). These compounds are not currently part of Halftime Health's published protocol catalog. This article is provided for educational purposes only and does not constitute medical advice or an offer to sell.
Frequently asked questions
Who searches for TB-500?
Mostly people nursing a soft-tissue injury — a tendon, a ligament, a stubborn shoulder — and people who heard about it on a recovery or longevity podcast. The shared question is whether the animal data carries over to humans.
Is TB-500 the same as thymosin beta-4?
TB-500 is a synthetic 17-amino-acid fragment of thymosin beta-4 (in plain English: the active piece of a larger repair protein the body makes). The fragment carries the part used in published research.
Is TB-500 FDA-approved?
No. TB-500 is not FDA-approved. As of 2026 it sits on the FDA's Category 2 list and is not currently available from 503A compounding pharmacies.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.